中国医院用药评价与分析2006，Vol.6Issue(1)：39-42,4.
加替沙星序贯疗法治疗下呼吸道感染的临床研究
Clinical Research of Gatifloxacin Sequential Therapy for the Treatment of Lower Respiratory Tract Infection
刘如品 1刘国清 1杨秀霞 1徐金霞 1刘玉琴 2李清芳3
作者信息
- 1. 河南省信阳市中心医院临床药学研究室,信阳市,464000
- 2. 北京大学深圳医院,深圳市,518000
- 3. 河南省开封市药检所,开封市,475100
- 折叠
摘要
Abstract
OBJECTIVE:To evaluate the clinical efficacy of gatifloxacin sequential therapy for the treatment of lowerrespiratory tract infection (LRTI). METHODS: 128 patients with LRTI were randomly divided into two groups (test and control groups). 62 patients in test group were treated firstly with 0.2g gatifloxacin iv. Injection, twice a day for three days,then were given 0.2g gatifloxacin capsules, twice a day for seven days; sixty six patients in control group were treated with gatifloxacin 0.2g iv injection, twice a day for ten days. RESULTS: The total effective rates of two groups were 93.3 % and 94.1%; cure rate were 74.19% and 75.76%. There was no significant difference( P ＞ 0.05). Sequential therapy can save 666.2 yuan per capita. CONCLUSION: Gatifloxacin sequential therapy has similar clinical efficacy to that of gatifloxacin injection, but it is cheaper in the cost. So gatifloxacin sequential therapy is an effective and safe way for the treatment of lower respiratory tract infection.关键词
加替沙星/下呼吸道感染/序贯疗法/细菌感染Key words
gatifloxacin/lower respiratory tract infection/sequential therapy/bacterial infection分类
医药卫生引用本文复制引用
刘如品,刘国清,杨秀霞,徐金霞,刘玉琴,李清芳..加替沙星序贯疗法治疗下呼吸道感染的临床研究[J].中国医院用药评价与分析,2006,6(1):39-42,4.
